Imaging and focal therapy of early prostate cancer /

Saved in:
Bibliographic Details
Edition:Second edition.
Imprint:Cham, Switzerland : Springer, 2017.
Description:1 online resource : illustrations (some color)
Language:English
Series:Current clinical urology
Current clinical urology.
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/11271744
Hidden Bibliographic Details
Other authors / contributors:Polascik, Thomas J., editor.
ISBN:9783319499116
3319499114
9783319499109
3319499106
Digital file characteristics:text file
PDF
Notes:Includes index.
Includes bibliographical references and index.
Online resource; title from PDF title page (SpringerLink, viewed March 6, 2017).
Summary:This book evaluates the trend to treat low risk, clinically localized prostate cancer in a focally ablative manner with novel gland-preserving, focal therapy methods. It examines the latest clinical applications of image-guided diagnosis and treatment.
Other form:Print version: Imaging and focal therapy of early prostate cancer. Second edition. Cham, Switzerland : Springer, 2017 3319499106 9783319499109
Standard no.:10.1007/978-3-319-49911-6

MARC

LEADER 00000cam a2200000Ii 4500
001 11271744
006 m o d
007 cr cnu|||unuuu
008 170227s2017 sz a ob 001 0 eng d
005 20240624203732.6
016 7 |a 019098251  |2 Uk 
019 |a 973916665  |a 974020948  |a 974324275  |a 974448298  |a 974546642  |a 974592293  |a 974684016  |a 975008979  |a 975078082  |a 985035254  |a 1005799991  |a 1011792421  |a 1048180059  |a 1058142804  |a 1066471624  |a 1070585827  |a 1084364039  |a 1086558012  |a 1112584152  |a 1160028417 
020 |a 9783319499116  |q (electronic bk.) 
020 |a 3319499114  |q (electronic bk.) 
020 |z 9783319499109  |q (print) 
020 |z 3319499106 
024 7 |a 10.1007/978-3-319-49911-6  |2 doi 
035 |a (OCoLC)973882432  |z (OCoLC)973916665  |z (OCoLC)974020948  |z (OCoLC)974324275  |z (OCoLC)974448298  |z (OCoLC)974546642  |z (OCoLC)974592293  |z (OCoLC)974684016  |z (OCoLC)975008979  |z (OCoLC)975078082  |z (OCoLC)985035254  |z (OCoLC)1005799991  |z (OCoLC)1011792421  |z (OCoLC)1048180059  |z (OCoLC)1058142804  |z (OCoLC)1066471624  |z (OCoLC)1070585827  |z (OCoLC)1084364039  |z (OCoLC)1086558012  |z (OCoLC)1112584152  |z (OCoLC)1160028417 
035 9 |a (OCLCCM-CC)973882432 
037 |a com.springer.onix.9783319499116  |b Springer Nature 
040 |a N$T  |b eng  |e rda  |e pn  |c N$T  |d GW5XE  |d N$T  |d YDX  |d EBLCP  |d UAB  |d OCLCF  |d COO  |d AZU  |d IOG  |d OCLCO  |d VT2  |d UPM  |d MERER  |d ESU  |d Z5A  |d OCLCO  |d OCLCQ  |d OCLCO  |d JBG  |d IAD  |d OCLCO  |d ICW  |d OCLCO  |d ICN  |d OCLCQ  |d OCLCO  |d OTZ  |d OCLCQ  |d OCLCO  |d U3W  |d OCLCO  |d OCLCA  |d CAUOI  |d KSU  |d AU@  |d OCLCO  |d OCLCQ  |d WYU  |d OCLCO  |d OCLCA  |d UKMGB  |d OCLCO  |d OCLCA  |d OCLCQ  |d OCLCO  |d AUD  |d OCLCQ  |d OCLCO  |d UKAHL  |d OCLCQ  |d CASUM  |d ERF  |d OCLCQ  |d OCLCA  |d OCLCQ  |d SRU  |d ADU  |d OCLCQ  |d OCLCO 
049 |a MAIN 
050 4 |a RC280.P7 
060 4 |a WJ 762  |b .I31 2017 
072 7 |a MED  |x 062000  |2 bisacsh 
072 7 |a MJS  |2 bicssc 
245 0 0 |a Imaging and focal therapy of early prostate cancer /  |c Thomas J. Polascik, editor. 
250 |a Second edition. 
264 1 |a Cham, Switzerland :  |b Springer,  |c 2017. 
300 |a 1 online resource :  |b illustrations (some color) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file 
347 |b PDF 
490 1 |a Current clinical urology 
500 |a Includes index. 
588 0 |a Online resource; title from PDF title page (SpringerLink, viewed March 6, 2017). 
505 0 |a Foreword; The Best Is Still to Come ; Preface; Acknowledgements; Contents; Contributors; Part I: Why Focal Therapy?; 1: Evolution in€the€Concept of€Focal Therapy: The€Story of€Breast Cancer and€Prostate Cancer; Introduction; Breast Cancer; Introduction and€Background; Diagnostic and€Imaging; Surgical Treatment for€Breast Cancer; Palpable Lesions; Non-palpable Lesions; Sentinel Lymph Node and€Axillar Dissection; Conclusion; Prostate Cancer; Introduction and€Background; Diagnostic and€Imaging; Focal Therapy Treatment and€Its Evolution; Options of€Focal Therapy; Cryotherapy. 
505 8 |a High-Intensity Focused Ultrasound Photodynamic Therapy; Laser Interstitial Thermotherapy; Irreversible Electroporation; Conclusion; References; 2: Targeted Therapy for€Localized Kidney Cancer; Introduction; The Small Renal Mass Dilemma; Renal Biopsy; Role, Indications, and€Contraindications of€Ablative Therapy; Surgical Approach; Patient Preparation; Principles of€Ablation; Cryoablation; Radiofrequency Ablation; Cryoablation Techniques; Laparoscopic Cryoablation; Percutaneous Cryoablation; Oncological Outcomes and€Follow-up; Efficacy of€Cryoablation. 
505 8 |a Salvage Cryoablation in€the€Setting of€Recurrence Following€Primary Cryoablation Efficacy of€Radiofrequency Ablation; Conclusion; References; 3: Focal Therapy for€Prostate Cancer: A€Guide for€Patients; Introduction; Treatment Options for€Prostate Cancer; Traditional Radical Therapies; Active Surveillance; Focal Therapy; Determining if Focal Therapy Is Suitable for€You; Why Consider Focal Therapy?; Cancer Treatment Needs; Biopsy of€the€Prostate; Imaging; Personal Needs; Mindset and€Personality; Summary: Signs that Focal Therapy May Be€a€Good Fit for€You. 
505 8 |a Types of€Ablative Technology Available for€Focal Therapy What to€Expect During€the€Treatment Process; What to€Expect Immediately After€Treatment; Long-Term Functional and€Oncological Outcomes after€Focal Therapy; Functional Outcomes; Cancer Treatment Outcomes and€Posttreatment Surveillance; Conclusion; Part II: Global Perspective of Active Surveillance and Focal Therapy; 4: Low-Risk Prostate Cancer in€North America: Rationale, Uptake, and€Limitations of€Active Surveillance and€Opportunities for€Focal Therapy; Introduction. 
505 8 |a The Rationale for€Active Surveillance of€Low-Risk Prostate Cancer North American Uptake of€Active Surveillance; The Limitations of€Active Surveillance; Boundary Between€Active Surveillance and€Focal Therapy; Conclusion; References; 5: Focal Therapy and€Active Surveillance in€Europe; Introduction; Active Surveillance in€Europe; Criteria for€Active Surveillance Inclusion; Repeat Prostate Biopsy Under€Active Surveillance; The Role of€Prostate-Specific Antigen and€Serum Biomarkers; Urinary and€Tissue Markers. 
520 |a This book evaluates the trend to treat low risk, clinically localized prostate cancer in a focally ablative manner with novel gland-preserving, focal therapy methods. It examines the latest clinical applications of image-guided diagnosis and treatment. 
504 |a Includes bibliographical references and index. 
650 0 |a Prostate  |x Cancer  |x Diagnosis. 
650 0 |a Prostate  |x Cancer  |x Treatment. 
650 2 |a Prostatic Neoplasms  |x therapy. 
650 2 |a Diagnostic Imaging. 
650 7 |a Oncology.  |2 bicssc 
650 7 |a Radiology.  |2 bicssc 
650 7 |a Urology & urogenital medicine.  |2 bicssc 
650 7 |a MEDICAL  |x Oncology.  |2 bisacsh 
650 7 |a Médecine.  |2 eclas 
650 7 |a Prostate  |x Cancer  |x Diagnosis.  |2 fast  |0 (OCoLC)fst01079483 
650 7 |a Prostate  |x Cancer  |x Treatment.  |2 fast  |0 (OCoLC)fst01079496 
655 4 |a Electronic books. 
700 1 |a Polascik, Thomas J.,  |e editor. 
776 0 8 |i Print version:  |t Imaging and focal therapy of early prostate cancer.  |b Second edition.  |d Cham, Switzerland : Springer, 2017  |z 3319499106  |z 9783319499109  |w (OCoLC)961410368 
830 0 |a Current clinical urology.  |0 http://id.loc.gov/authorities/names/n99801681 
903 |a HeVa 
929 |a oclccm 
999 f f |i 9f437707-60a5-5d48-863a-ecccc8028b4e  |s 7586e84d-0f48-5709-a365-ff43efdd85e8 
928 |t Library of Congress classification  |a RC280.P7  |l Online  |c UC-FullText  |u https://link.springer.com/10.1007/978-3-319-49911-6  |z Springer Nature  |g ebooks  |i 12544305